# Apimostinel + Automated Neurocognitive Training for Depression

> **NCT06400121** · PHASE2 · RECRUITING · sponsor: **Rebecca Price** · enrollment: 150 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Apimostinel Infusion, Intravenous
- **BEHAVIORAL:** Cognitive Training
- **BEHAVIORAL:** Sham Training
- **DRUG:** Isotonic Solution, Intravenous

## Key facts

- **NCT ID:** NCT06400121
- **Lead sponsor:** Rebecca Price
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-28
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400121, "Apimostinel + Automated Neurocognitive Training for Depression". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06400121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*